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Abstract
Background: MSCs secretome is under investigation as an alternative to whole-cell-based therapies, since it is
enriched of bioactive molecules: growth factors, cytokines and chemokines. Taking into account the translational
value of the pig model, the leading aim of the present paper was to characterize the secretome of porcine Vascular
Wall–Mesenchymal Stem Cells (pVW-MSCs) and its change in presence of LPS stimulation. Moreover, considering
the importance of angiogenesis in regenerative mechanisms, we analysed the effect of pVW-MSCs secretome on in
vitro angiogenesis.
Results: Our results demonstrated that conditioned medium from unstimulated pVW-MSCs contained high levels
of IL-8, GM-CSF, IFN-γ and other immunomodulatory proteins: IL-6 IL-18 IL-4 IL-2 IL-10. LPS modulates pVW-MSCs
gene expression and secretome composition, in particular a significant increase of IL-6 and IL-8 was observed;
conversely, the amount of GM-CSF, IFN-γ, IL-2, IL-4, IL-10 and IL-18 showed a significant transient decrease with the
LPS stimulation. Conditioned medium from unstimulated pVW-MSCs induced in vitro endothelial angiogenesis,
which is more evident when the conditioned medium was from LPS stimulated pVW-MSCs.
Conclusions: The lines of evidence here presented shed a light on possible future application of secretome
derived by pVW-MSCs on research studies in translational regenerative medicine.
Keywords: Secretome, Vascular Wall-MSCs, Pig animal model, Angiogenesis
Background
Increasing evidences have confirmed the dynamic nature
of blood vessels, defining the vasculature as a reservoir
for a range of multipotent and lineage-restricted pro-
genitor cells, both during embryonic and postnatal life
[1–3]. In order to simplify the copious classification,
some authors have identified two main classes of
multipotent mesenchymogenic populations derived
from vessels: microvascular multipotent pericytes [4]
and Vascular Wall Mesenchymal Stem Cells
(VW-MSCs) [5, 6].
The presence of pro-angiogenic progenitor cells in the
arterial wall, including aorta, has been shown in different
species including human [7–9], mouse [10] and rat [11].
Many similarities between human and porcine Mesen-
chymal Stem Cells (MSCs) has been demonstrated
[12–15] confirming the swine as an excellent transla-
tional model also in the field of regenerative medicine.
Furthermore, we have established that porcine Aortic
Vascular Precursor Cells (pAVPCs) possess pro-angio-
genic features for their ability to differentiate toward the
endothelial phenotype and also for their pericyte-like
proprieties [16]. Taking into account all these observa-
tions we could classify them as porcine Vascular Wall–
MSCs (pVW-MSCs) [6].
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Regardless their vascular origin, vascular stem cells ex-
hibit an intrinsic pro-angiogenic attitude by different fea-
tures: the capacity of differentiating towards endothelial
phenotype, the ability to sustain the formation of a capil-
lary network [9, 11, 17, 18] and the secretion of angiogenic
factors including bFGF, VEGF, TGF-β, PDGF, IL-6, and
IL-8 [19]. Overall, vascular stem cells can reasonably be
considered for their application in the field of regenerative
medicine. To date clinical treatments with MSCs are
based on their transplantation [20] but the main drawback
associated with these current therapies is represented by
bio-distribution of injected cells. Indeed, whole-cell sys-
temic treatment is mostly applied for those disorders in
which the site for MSCs putative therapeutic activity is
where cells remain entrapped once in the system, as in the
alveolar microcirculation [21]. Some reports ascribed
MSCs regenerative ability to the paracrine effects exerted
by the MSCs-derived mediators. Accordingly, MSCs
secretome is under investigation as an alternative to
whole-cell-based therapies [22]. MSCs secretome is
enriched of bioactive factors, such as growth factors, cyto-
kines and chemokines known to modulate immune re-
sponse, inhibit apoptosis and fibrosis and enhance
angiogenesis by stimulating differentiation of tissue resi-
dent progenitor cells [23, 24]. The secretome composition
may vary widely depending on the source tissue and can
be modulated by different stimuli. Among vascular stem
cells, microvascular pericyte release a heterogenous secre-
tome in response to high glucose concentrations [25], or
inflammatory interleukins [26]. Moreover, LPS binding of
Toll-Like Receptor4 (TLR4) on perycites induces the se-
cretion of several pleiotropic cytokines such as IL-6, IL-8
and chemokines CXCL10, CCL2 [26].
Taking into account the translational value of the pig
model and considering our previous data describing the
marked angiogenic properties of pVW-MSCs, the lead-
ing aim of the present work was to characterize
pVW-MSCs secretome. Therefore, we studied the
change of pVW-MSCs secretome induced by LPS stimu-
lation, after checked the presence of TLR4 on
pVW-MSCs. Furthermore, in order to address a possible
application of pVW-MSCs secretome in the study of
reparative medicine, we analysed the effect of condi-
tioned medium by unstimulated or LPS-stimulated
pVW-MSCs on in vitro angiogenesis.
Results
TLR4 expression in pVW-MSCs
First of all, we assessed the TLR4 receptor expression by
flow cytometry both in not-fixed and not-permeabilized
cells than in fixed and permeabilized pVW-MSCs.
Cytofluorimetric analysis showed that TLR4 was
expressed in the pVW-MSCs cells at each experimental
time point. In particular, the untreated cells showed an
high level (97.91 ± 2.34%) of total TLR4 in nearly the to-
tality of cell population as shown in fixed and perme-
abilized samples (Fig. 1a). Differently, surface TLR4
expression was markedly lower (10.43 ± 1.77%) (Fig. 1a).
After 1 h of LPS stimulation, TLR4 signal disappeared
completely in the surface even if the total expression
levels remained essentially unchanged (97.01 ± 3.35%).
After 4 h of LPS stimulation, total TLR4, that is the sum
of surface and intracellular receptor, expression mark-
edly decreased not only on the surface but also as a
whole (CTR 98.47 ± 2.67%, LPS 10 μg/ml 5.93 ± 1.11%).
A recovery period of 24 h after 4 h of LPS stimulation
re-established the level of total TLR4 expression (99.58
± 2.63%). Western blot and (Fig. 1b) confirmed the ex-
pression of TLR4 in pVW-MSCs and its decrease after
4 h of LPS stimulation. The immunofluorescence ana-
lysis showed a drastic reduction of positive cells after
LPS treatment (98 ± 2 vs 3 ± 1 95%) (Fig. 1c).
pVW-MSCs characterization after LPS treatment
No sign of toxicity was evidenced by MTT test after LPS
treatment at the doses and times used (data not shown).
Therefore, we assessed whether LPS treatment could cause
any change of pVW-MSCs phenotype. pVW-MSCs showed
a thin spindle-shaped morphology typical for mesenchymal
and vascular wall mesenchymal cells; LPS treatment (10 μg/
ml 4 h) did not alter this characteristic cellular morphology
(Fig. 2a). pVW-MSCs showed a standard cell cycle character-
izing diploid cells (CTR: phase G0-G1 84.92 ± 5%, phase S
8.76 ± 0,3%, phase G2-M 6.32 ± 0.3%) that remained un-
changed after LPS treatment (LPS: phase G0-G1 84.22 ± 5%,
phase S 9.04 ± 0.8%, phase G2-M 6.74 ± 0.3%) (Fig. 2b).
Cytofluorimetric analysis (Fig. 2c) confirmed that LPS treat-
ment did not alter pVW-MSCs positivity for major MSC
markers: CD105 (CTR 96.8 ± 0.4% vs LPS 96.3 ± 0.2%),
CD90 (CTR 96.2 ± 0.3% vs LPS 96.5 ± 0.1%), CD56 (CTR
98.4 ± 0.3% vs LPS 98.8 ± 0.3%), CD44 (CTR 99.4 ± 0.2% vs
LPS 99.4 ± 0.1%). Negative immunoreactivity for
hematopoietic CD45 (CTR 2.6 ± 0.7% vs LPS 2.7 ± 0.6%) and
endothelial markers CD34 (CTR 2.7 ± 0.9% vs LPS 1.7 ±
0.4%) remained unchanged. In order to investigate the pos-
sible effect of LPS on gene expression of potential secreted
molecules we used a panel of porcine cytokines and chemo-
kines genes. After LPS treatment, pVW-MSCs showed an al-
tered gene expression profile: among the 84 genes of the RT2
Profiler™ PCR Array Pig Cytokines & Chemokines, 30 genes
were upregulated (fold of change > 2). Among these genes, 9
were expressed more than 100-fold (Fig. 3a).
The array validation of selected genes (fold of change
> 100), confirmed the gene expression profile deter-
mined by the array analysis. The lowest dose too (LPS
0.1 μg/ml) was effective in stimulating the expression of
the same selected genes (Fig. 3b).
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Fig. 2 Phenotypic analysis of LPS treated pVW-MSCs. Cells were cultured with or without LPS (10 μg/ml) for 4 h. a: representative images of pVW-
MSCs morphology. Scale bar = 100 μm. b: cell cycle analysis: red: cells in G0-G1 phase, yellow: cells in S phase, green: cells in G2-M phase. c:
immunophenotyping: flow cytometry analysis for mesenchymal markers: grey histograms: unstained cells, blue histograms: control cells, red
histograms: LPS-treated cells. Results are representative of three biological replicates; each experiment is repeated three times
Fig. 1 TLR4 expression in pVW-MSCs cultured with or without LPS (10 μg/ml) for 1 and 4 h and after additional 24 h of recovery after LPS removal
(4hR). a: flow cytometry analysis were performed in not fixed and not permeabilized cells for TLR4 surface expression determination (TLR4:
Surface) and in fixed and permeabilized cells to measure the overall TLR4 amount (TLR4: Total). Red histograms: stained cells; blue histograms:
control cells. b: representative Western Blot of TLR4 and housekeeping β-tubulin and relative quantification were presented. c: representative
images of TLR4 immunostaining of pVW-MSCs cultured with or without LPS (10 μg/ml) for 4 h. pVW-MSCs nuclei were stained with Hoechst
33258 (blue). Scale bar = 10 μm. Data shown represent the mean ± SD of three biological replicates, each experiment is repeated three times.
Data were analysed using one-way ANOVA followed by the Tukey’s post hoc comparison test. Different letters above the bars indicate significant
differences (p < 0.05). (AU = Arbitrary Units)
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Cytokines and chemokines presence in pVW-MSCs
conditioned media and their alteration induced by LPS
treatment
CM from unstimulated pVW-MSCs contained high levels
of and IL-8 (1514 ± 77.1 pg/ml), GM-CSF (230 ± 5.3 pg/
ml), IFN-γ (199 ± 13.8 pg/ml); other immunomodulatory
proteins were also detected: IL-6 (53.5 ± 3.8 pg/ml), IL-18
(44 ± 5.6 pg/ml). IL-4 (24.07 ± 3.38 pg/ml), IL-2 (19.16 ±
2.38 pg/ml), IL-10 (18.7 ± 0.9 pg/mL) (Fig. 4a).
CM0.1 and CM10, derived from LPS stimulated
pVW-MSCs, showed a significant increase of IL-6 and
IL-8; this increase was maintained also at the end of re-
covery time with IL-8 showing an additional noticeable
increase (CM0.1R and CM10R) (Fig. 4b).
Fig. 3 Transcriptional profile of cytokine and chemokine in pVW-MSCs after LPS treatment a: cytokines and chemokines relative expression
evaluated by RT2 Profiler™ PCR Array Pig Cytokines & Chemokines in pVW-MSCs cultured with LPS (10 μg/ml) for 4 h. b: qRT-PCR analysis of
selected genes in pVW-MSCs cultured in control condition and with LPS 0.1 μg/ml or10 μg/ml for 4 h. Data represent the mean ± the range of
relative expression of three biological replicates, each experiment is repeated two times. Data were analysed using one-way ANOVA followed by
the Tukey’s post hoc comparison test. Different letters above the bars indicate significant differences (p < 0.05). The relative mRNA expression (fold
of change) was calculated in relation to control cells using the 2-ΔΔct method. nd = not detectable
Bernardini et al. BMC Veterinary Research          (2019) 15:123 Page 4 of 12
Conversely, the amount of GM-CSF, IFN-γ, IL-2, IL-4,
IL-10 and IL-18 showed a significant transient decrease
with the LPS stimulation (CM0.1 and CM10) and re-
stored the basal levels after recovery time (CM0.1R and
CM10R) (Fig. 4b).
IL-1α, IL-1β, IL-1ra, IL-12 and TNF were undetectable
in all CMs (data not shown).
Effect of conditioned media on endothelial cell
angiogenesis
The addition of CM from unstimulated pVW-MSCs to
the endothelial medium stimulated pAECs to form a
better structured capillary-like network (Fig. 5a, c) com-
pared to the addition of PGM unconditioned medium
(UM) (Fig. 5a, c).
CM0.1 and CM10, derived by LPS-stimulated
pVW-MSCs, showed a stronger capacity to induce tube
formation compared to the medium from the unstimu-
lated pVW-MSCs (CM) (Fig. 5b, c).
CM0.1R and CM10R also exhibited high capacity of
inducing capillary-like network (Fig. 5b).
CMs effect on endothelial cells migration was demon-
strated by scratch test. After 24 h from scratch (T1) un-
stimulated pVW-MSCs CM induced a significant
decrease of the damaged area compared to PGM uncon-
ditioned medium (UM) (Fig. 5d-f ). Besides, CM0.1,
CM10, CM0.1 R and CM10 R were able to increase
endothelial migration reducing damaged area (Fig. 5e-f ).
Discussion
Over the last decade, a remarkable interest of the scien-
tific community aroused after the discovery of a
heterogeneous population of stem cells residing in both
microvascular and large vessel, which are involved in the
regulation of the vascular physiological homeostasis [5,
6, 27, 28]. Among the stem cells resident in large vessels,
those isolated from the aorta showed great
pro-angiogenic attitudes [9, 29, 30]. As swine is consid-
ered an excellent model for translational purpose, espe-
cially in the cardiovascular research area [31–33], we
described a new method to obtain vascular precursor
cells from pig thoracic aorta: pVW-MSCs [15, 16]. These
cells show mesenchymal properties and the ability to dif-
ferentiate in all the components of a functional vessel.
Furthermore, pVW-MSCs sustain capillary-like tube for-
mation in vitro, showing pericyte-like properties, while
environmental stressors [34] impaired this ability.
In the present paper, we focus attention on
pVW-MSCs secretome. Considering that LPS is the
most studied pericyte-activating molecules in vitro we
first verified the TLR4 presence in pVW-MSCs. In fact
the presence and role of TLR4 in adult stem cells are
currently under debate [35, 36], in particular, TLR4 ex-
pression in MSCs. In this regard, Chen and colleagues
[37] determined low levels of TLR4 in human Umbelical
Cord-MSCs, conversely, TLR4 is highly expressed in hu-
man adipose MSCs [38]. Moreover, Raicevic et al. [39]
did not detect TLR4 on human Wharton’s Jelly-derived
MSCs. Our data showed not only TLR4 presence in
pVW-MSC but also the LPS ability to modulate its ex-
pression. In particular, we detected a decrease of the sur-
face fraction of TLR4 induced by LPS stimulation, while
the total amount did not change. The persistence of LPS
stimulus resulted in a reduction of the total amount of
Fig. 4 Cytokines in pVW-MSCs conditionate medium. a: the concentration of cytokines/chemokines was measured in conditioned medium
obtained from unstimulated pVW-MSCs (CM), unconditioned medium (UM). Data represent the mean ± SD of three biological replicates, each
experiment was repeated three times. Data were analysed using Student’s t-test. Significant differences are indicated by *p < 0.05, **p < 0.01, ***p
< 0.001. b: the concentration of cytokines was measured in conditioned medium obtained from pVW-MSCs treated LPS with LPS 0.1 μg/ml (CM
0.1), 10 μg/ml (CM 10) and from recovery time (CM0.1R; CM10R). Data represent three biological replicates, each experiment was repeated three
times and represent the mean ± SD. Data were analysed using one-way ANOVA followed by the Tukey’s post hoc comparison test. Different
letters above the bars indicate significant differences (p < 0.05)
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the receptor, which is restored after a recovery period of
24 h. Therefore, our results show the expression of this
ancestral receptor on pVW-MSCs and this is in agree-
ment with previous studies on TLR4 expression in hu-
man multipotent pericytes [40].
Upon these bases, we used LPS as a priming stimulus
to investigate pVW-MSCs secretome in mild challenging
conditions. In fact, LPS at the concentrations and time
used in the present paper did not affect pVW-MSCs
morphology, viability, cell cycle and immunophenotype.
However, pVW-MSCs gene expression is markedly al-
tered. LPS evoked a cytokine response as shown by the
high level of TNF-α, IL-6, IL-8, IL-1α, IL-1β along with
an increase of other immunomodulatory molecules
(CXCL2, CXCL10 CCL20, CSF2). These results are in
line with results obtained with MSCs derived from dif-
ferent sources, including multipotent microvascular hu-
man pericytes, (16), human adipose-derived stem cells
(29), human bone marrow-derived MSCs [37, 40–42].
The analysis of the presence of cytokines and chemo-
kines in unstimulated pVW-MSCs conditioned medium
showed for the first time the presence of molecules with
strong immunomodulatory properties such as GM-CSF
and IFN-γ, as also reported for cultured MSCs [43].
Fig. 5 Effect of pVW-MSCs conditioned medium on endothelial cells angiogenesis. a: the presence of pVW-MSCs conditioned medium (CM)
induced endothelial cells to form a capillary like network compared to unconditioned medium (UM). b: pAECs cultured in extracellular matrix
coating were exposed to conditioned medium obtained from unstimulated pVW-MSCs (CM) or 0.1 and 10 μg/ml LPS treated pVW-MSCs (CM 0.1;
CM 10) and from recovery (CM0.1R; CM10R). c: representative images of pAECs in vitro angiogenesis in the presence of UM, CM, CM10, CM10.
Scale bar = 100 μm. d, e, f: the effect of conditioned medium on endothelial cells migratory capacity was demonstrated by scratch test. Confluent
pAECs were scratched (T0) and exposed to UM and CM, CM0.1, CM10, CM0.1R, CM10R for 24 h (T1). All data shown represent the mean ± SD of
three biological replicates, each experiment is repeated two times. Data (Fig. a, d, e) were analysed using Student’s t-test between different
treatment (UM vs CM) or different time (T0 vs T1) for each treatment. Significant differences are indicated by *(p < 0.05) and **(p < 0.01). Data (Fig.
b) was analysed using one-way ANOVA followed by the Tukey’s post hoc comparison test, different letters above the bars indicate significant
differences (p < 0.05)
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Considerable levels of IL-8 and IL-6 were also detected
in agreement with what evidenced in conditioned
medium of other tissue-specific stem cells such as
Wharton’s Jelly-derived MSCs [44] and endometrial
MSCs [45].
The secretome composition changed after pVW-MSC
challenge with LPS. IL-6 and IL-8, dramatically increase
conversely, GM-CSF, IFN-γ, IL-2, IL-4, IL-10 and IL-18
levels decreased. Nevertheless, the basal levels of ana-
lysed molecules are restored after the 24-h recovery
time, except for IL-6 and IL-8, which kept increasing.
Finally, TNF-α, IL-1α, IL-1β are not detected in the
culture medium of pVW-MSCs in any of the experimen-
tal conditions tested, although gene expression of these
cytokines was increased by LPS. Therefore further inves-
tigations are warranted to clarify the specific regulation
of these cytokines.
An increasing number of paper showed that MSCs can
induce angiogenesis through paracrine effects [46, 47] in
the present paper we demonstrated the effects of un-
stimulated pVW-MSCs secretome on endothelial cell
angiogenesis. In fact, the addition of pVW-MSCs condi-
tioned medium induced in vitro angiogenesis and endo-
thelial cell migration, confirming high pro-angiogenic
effect not only exerted by the cells, but also by mole-
cules secreted. Overall in the present paper we demon-
strated the paracrine properties of pVW-MSCs in line
with those described for MSC [48].
Priming pVW-MSCs with LPS at different concentra-
tions enhanced both pro-angiogenic effect and the cap-
acity to induce endothelial cell migration. Moreover,
similar effects are obtained by the conditioned medium
of pVW-MSCs after 24 h of recovery from the LPS
stimulus.
This evident in vitro effect on endothelial cells could
be reasonably ascribed to the endothelial CXC receptor
2 (CXCR2) activation caused by the observed high levels
of IL-8 [49]. However, we can not rule out that other im-
portant components present in the conditioned medium
of pVW-MSCs may play a role in the induction of angio-
genesis. In fact, it was recently demonstrated that MSCs
could release exosomes that transfer miRNAs to endothe-
lial cells promoting angiogenesis [50]. Therefore, further
studies are necessary to investigate the presence of exo-
somes, microvescicles and miRNAs in pVW-MSCs condi-
tioned medium.
Conclusions
Overall, our results demonstrated for the first time the
presence of powerful regulatory molecules secreted by
pVW-MSCs. The composition of secretome is altered by
LPS challenge and some of these differences are kept
even after a recovery time. In particular, IL-6 and IL-8
seems strongly regulated. The pVW-MSCs secretome,
both unstimulated and LPS induced, is active in the
modulation of in vitro angiogenesis.
Although our results are limited to an in vitro ap-
proach, this is a fundamental step toward
better-designed in vivo experiments, according to
commonly-accepted 3Rs rules (Replacement, Reduction
and Refinement) [51, 52] for more ethical use of animals
in experimental testing and the European Directive on
the protection of animals used for scientific purposes
(Directive 2010/63/EU) [53]. Therefore the lines of evi-
dence here presented shed a light on possible future ap-
plication of secretome derived by pVW-MSCs on
research studies in translational regenerative medicine.
Methods
Chemicals and reagents
Heat inactivated FBS (fetal bovine serum), antibiotic–
antimycotic, Dulbecco’s phosphate buffered saline
(DPBS), high glucose (hg) DMEM, M199, Endothelial
Cell Growth Medium (ECM) and Geltrex™ LDEV-Free
Reduced Growth Factor Basement Membrane Matrix
and NuPage 4–12% bis-Tris Gel, were purchased from
Gibco-Life Technologies (Carlsbad CA, USA). Trypsin–
EDTA solution1X, Dimethyl sulphoxide (DMSO), lipo-
polysaccharide (LPS) (E. coli 055:B5), Protein Assay Kit
TP0300, In Vitro Toxicology Assay Kit and Cell Growth
Determination Kit MTT based were purchased from
Sigma-Aldrich (St. Louis, MO, USA). Pericyte Growth
Medium was purchased from Promocell (Heidelberg,
Germany). NucleoSpin RNA kit was purchased from
Macherey-Nagel GmbH & Co. KG (Düren, Germany)
RT2 strand kit, RT2 Sybr green fluor qPCR master mix
were from Qiagen (Hilden, Germany). Porcine Cytokine/
Chemokine Magnetic Bead Panel kit, Milliplex Map Kit
EMD was purchased by Millipore Corporation (Billerica,
MA, USA). Super Signal West Pico Chemiluminescent
Substrate was from Pierce Biotechnology, Inc. (Rockford,
IL, USA).
Cell culture
pVW-MSCs were isolated from female 3-mo-old pigs
(Large White) euthanized for other experimental pur-
poses, following the published methods previously de-
scribed [15], to generate three primary cell culture
replicates. All procedures on pigs were reviewed and ap-
proved in advance by the Ethical Committee of the
University of Bologna (Bologna, Italy) and were then ap-
proved by the Italian Ministry of Health (Protocol num-
ber n.43-IX/9 all.37; 20/11/2012). Briefly, cells were
isolated from the media layer of the aortas through an
enzymatic digestion and cultured overnight in high
glucose (hg) DMEM 10% FBS and 10X
antibiotic-antimycotic (hgDMEM-10X) in a 5% CO2 in-
cubator at 38.5 °C. The day after the culture medium
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was replaced by hgDMEM + 10% FBS (GIBCO) + 1X
antibiotic-antimycotic (GIBCO) (hgDMEM-1X). After 3
days cells were serum starved overnight and then cul-
tured in hgDMEM:M199 (GIBCO) (1:1) 10% FBS 1X
antibiotic-antimycotic (DM medium). Then cells were
trypsinized, grown and expanded not beyond till passage
(P) 6 in Pericyte Growth Medium (PGM – Promocell,
Heidelberg, Germany). All the experiments described in
this paper were performed with cells at the third passage
(P3), cultured in Pericyte Growth Medium (PGM).
The LPS treatments were performed once reached
80% confluence as reported in the specific sections, cells
viability after the treatments was determined by MTT
test (In vitro Toxicology assay kit, MTT based
TOX1-1KT, Sigma). Porcine Aortic Endothelial Cells
(pAECs) were isolated by thoracic aorta of animals
slaughtered at a local slaughterhouse and cultured as
previously described [54].
Preparation of conditioned media
Once established that the treatment with LPS for 4 h
had no effects on cell cycle, nor on the mesenchymal
phenotype, we proceeded with the preparation of the
conditioned media. pVW-MSCs from three primary cell
cultures, were plated in a 24-multi well plate at a con-
centration of 3 × 104 cells/well. The day after, the cells
were washed three times with DPBS, and then fresh
medium with LPS (0; 0.1 and 10 μg/ml) was added. After
4 h, Conditioned Medium (CM) from pVW-MSCs
treated with 0.1 μg/ml LPS (CM 0.1), 10 μg/ml LPS (CM
10) or without LPS (CM) was collected.
An additional experiment was conducted to produce
CM from recovery (CM0.1R; CM10R): after 4 h of LPS
treatment, the cells were washed three times with DPBS,
then fresh medium (PGM) was added and the cells were
incubated for 24 h (R recovery time).
All collected media were centrifuged at 800 x g for 10
min, filtered through a 0.20-μm syringe filter and imme-
diately frozen in liquid nitrogen.
Unconditioned medium (UM), namely the Pericyte
Growth Medium, was used as control.
pVW-MSCs immunophenotyping and DNA content by
flow cytometry
All cytofluorimetric assays were performed with the em-
ployment of MacsQuant10 Cytometer and analysed with
Flowlogic™ software (Miltenyi Biotec, Bergisch Gladbach,
Germany).
LPS was used only as a priming to stimulate secretome
change, therefore alteration of pVW-MSCs immunophe-
notype and/or cell cycle were evaluated. Briefly, CD90,
CD105, CD56, CD44, CD45 and CD34 expression were
evaluated in LPS-treated and in control cells as previ-
ously indicated [15, 16].
For cell cycle analysis pVW-MSCs were centrifuged at
500 x g for 10 min and counted by a hemocytometer.
Appropriate volume of 70% ice-cold ethanol (1 ml/106
cells) was added drop-by-drop to cellular pellet vortex-
ing. Single cell suspension was than fixed overnight at +
4 °C. The day after, cells were washed in PBS and incu-
bated for 20 min in the dark with the Staining Solution
[PI 50 μg/ml (Miltenyi Biotec, Bergisch Gladbach,
Germany), RNAseA/T1 Mix 100 Kunitz/ml (Thermo
Scientific, Waltham, MA, USA)]. For cell cycle analysis,
Dean-Jett-Fox Univariate Model was applied.
Determination of TLR4 expression on pVW-MSCs
The determination of TLR4 expression was performed
at the highest dose utilized (10 μg/ml) and after 1 and 4
h of exposure. An additional time point was represented
by cells exposed to LPS for 4 h and let to recover in
standard culture conditions (PGM) for other 24 h (R).
5 × 105 pVW-MSCs were seeded in T25 flasks and
LPS was added at 80% of confluence.
At each experimental time point, the cells were har-
vested and analyzed by flow cytometry, western blot and
immunocytochemistry.
TLR4 was determined by flow cytometry in fresh (not
fixed and not permeabilized cells) and in fixed/perme-
abilized cells to distinguish the amount of TLR4
expressed on the surface from the total one, that is the
amount of surface receptor and amount of intracellular
receptor. TLR4 determination was carried out by incu-
bating 1 × 106/100 μl cells with a specific antibody (1:50,
Mouse anti TLR4, NB100–56566 Novus Biologicals
Europe) for 60 min at 4 °C in the dark. After incubation,
cells were washed twice with DPBS and incubated with
secondary antibody (1:50, Anti-Mouse FITC-conjugated
F4143, Sigma Aldrich) for 40 min at 4 °C in the dark. At
the same time an equal amount of cells for each sample
and each time point was fixed and permeabilized with
FIX & PERM Cell Permeabilization Kit (Thermo Scien-
tific, Waltham, MA, USA) which allows fixation and
permeabilization of cells but, at the same time, leaves
their morphological scatter characteristics intact and so
it is suitable to accurately identify both superficial and
also intracellular markers.
For Western Blot analysis cells were lysed in SDS solu-
tion (Tris–HCl 50mM pH 6.8; SDS 2%; glycerol 5%).
Total protein amount was determined by Peterson’s
Modification of Lowry Method using a Protein Assay Kit
(Sigma). 20 μg of proteins were separated on 4–12%
bis-Tris Gel for 45 min at 165 V. Proteins were then
electrophoretically transferred onto a nitrocellulose
membrane by Turbo Blot System (Bio-Rad Laboratories
Inc., Hercules, CA, USA).
Non-specific binding on nitrocellulose membranes was
blocked with 5% milk powder in PBS-T20 (Phosphate
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Buffer Saline-0.1% Tween-20) for 1 h at room
temperature. Then, the membranes were probed for the
anti-TLR4 antibody (1:500) and an anti-β-tubulin anti-
body (1:500 of anti β-tubulin MA1–19162, Thermo
Fisher Scientific, Rockford, IL, USA). The membranes
were developed using a chemiluminescent kit according
to the manufacturer’s instructions (Clarity Biorad). The in-
tensity of the luminescent signal of the resultant specific
bands was acquired by Chemidoc Instrument using Inage
Lab Software (Bio-Rad). The relative protein content
(TLR4/β-tubulin) was expressed as arbitrary units (AUs).
In order to assess TLR4 by indirect immunofluores-
cence, pVW-MSCs were seeded on 8-well slide chamber
(BD Falcon Bedford, MA, USA) at a concentration of ~
3 × 104 cells/well and stimulated with LPS as indicated
above. At all experimental time points, pVW-MSCs were
washed in PBS and fixed in 4% paraformaldehyde for 20
min at RT. Subsequently, fixed cells were permeabilized
with 0.2% Triton-X100 in PBS for 3 min, washed in PBS
and blocked by 5% FBS in PBS (blocking solution) for 1
h at RT. The incubation with the anti TLR4 antibody di-
luted 1:50 in blocking solution was performed for 36 h
at 4 °C in humid atmosphere. Then cells were rinsed in
PBS and incubated with a fluorochrome-labeled second-
ary antibody (Goat anti-mouse AlexaFluor 594, A11032,
Thermo Fischer Scientific) diluted 1:400 added with
0.1 μg/mL Hoechst 33258 for nuclei staining in PBS for
1 h at RT. Negative controls were carried out by omit-
ting primary antibody. From each slide, at least 6 photo-
micrographs were acquired using an Eclipse E600
epifluorescence microscope equipped with a Nikon
digital camera and the ACT-2 U software for image cap-
turing (Nikon, Tokyo, Japan). Images were analyzed by
counting a minimum of 200 cells in order to evaluate
the number of positive cells.
Cytokines & chemokines analysis by RT2 assay and real-
time PCR
Total RNA from pVW-MSCs treated with or without
LPS 10 μg/ml, for 4 h was purified as previously de-
scribed [16] and quantified with nanospectrophotometer
(Denovix, Wilmington, DE, USA). 1 μg of RNA was
retro-transcribed using RT2 First Strand Kit (Qiagen,
Hilden, Germany) following the manufacturer’s instruc-
tions, in a 20 μl final volume to obtain cDNA. RT2 Pro-
filer™ PCR Array Pig Cytokines & Chemokines (Cat. No.
PASS-150Z, Qiagen, Hilden, Germany) was performed
according to the manufacturer’s instructions, using CFX
96 Touch (Bio-Rad Laboratories, Hercules, CA) on
cDNA pool of the three biological replicates.
In order to validate the Array results, qPCR real time
was performed for those genes up-regulated more than
100 times (TNFα; IL1-α; IL-1β; IL-6; IL-8; CXCL2;
CXCL10; CCL20; CSF2) respect to the control. A master
mix of the following reaction components was prepared
in a 25 μl final volume by using RT2 SYBR green master
mix and RT2 Primer Assay (RT2 qPCR Primer Assay for
Pig TNF-α, IL1-α, IL1-β, IL-6, IL-8, CXCL2, CXCL10,
CCL20, CSF2; Cat. No. PPS00426A, PPS00434A;
PPS00461B; PPS00991A; PPS00237A; PPS00036B;
PPS01275A; PPS01329A, PPS00543A respectively, Qia-
gen). cDNA was added to the master mix in a ratio of
1:25 in 25 μl total reaction value and amplified under the
following conditions:10 min at 95 °C, 40 cycles at 95 °C
for 15 s and at 60 °C for 30 s, followed by a melting step
from 55 °C to 95 °C (80 cycles of 0.5 °C increase/cycle).
Gene expression was evaluated using the ΔCt method
(reference gene Ct – interest gene Ct). Genes
up-regulated more than 100 times were studied for fur-
ther treatments with at a lower concentration of LPS
(0.1 μg/ml, 4 h).
The relative mRNA expression of the tested genes was
calculated in relation to the control cells using the 2-ΔΔct
method [55].
Multiparametric cytokines and chemokines quantification
Cytokines and chemokines were quantified in condi-
tioned medium (CM) by using the Porcine Cytokine/
Chemokine Magnetic Bead Panel kit (PCYTMAG Milli-
pore Corporation, Billerica, MA, USA) including
GM-CSF, IFN-γ, IL-1α, IL-1β, IL-1RA, IL-2, IL-4, IL-6,
IL-8, IL-10, IL-12, IL-18 and TNF-α, following the man-
ufacturer’s instructions. Luminex xMAP bead-based
multiplex immunoassay technology and MAGPIX in-
strument provided with xPONENT 4.2 software were
used (Luminex, Austin, TX, USA).
Evaluation of the effect of conditioned medium on
endothelial cells angiogenesis
To evaluate the effects of conditioned medium from
pVW-MSCs on endothelial cells angiogenesis, 30% of dif-
ferent CM (UM, CM0, CM0.1, CM10, CM0.1R,CM10R)
was added to the endothelial medium and pAECs were
tested for in vitro endothelial angiogenesis assays (tube
formation assay and scratch test).
To perform in vitro endothelial tube formation assay,
5 × 104/well pAECs were cultured in 8-well slide cham-
bers (BD Falcon Bedford, MA USA) coated with un-
diluted soluble form of basement membrane extracted
from murine Engelbreth-Holm-Swarm (EHS) tumors
[(Geltrex™ LDEV-Free Reduced Growth Factor Basement
Membrane Matrix (Catalog number: A1413201Thermo
Fisher)], as previously reported [15, 16]. Extracellular
matrix coating was carried out for 3 h in a humidified
incubator, at 38.5 °C, 5% CO2. At the end of experimen-
tal time (24 h), the images, acquired using a Nikon epi-
fluorescence microscope equipped with digital camera
(Nikon, Yokohama, Japan), were analysed by open
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software Image J 64 to measure the sum of length of the
segments in the analyzed area (Tot. segments length)
and the number of master junctions in the analyzed area
(Nb master junction).
To perform endothelial cell migration assay (Scratch
test), a wound was scratched with a pipette tip, in the
confluent pAECs layer in a 24-wells plate. Then, cells
were washed with DPBS to remove debries and complete
medium added with 30% of different CM was added.
Microscopic bright field pictures and three measure-
ments of the damaged areas were taken immediately
after the scratches (T0) and at the end of the experiment
(24 h, T1). Images were acquired using a Nikon epifluor-
escence microscope equipped with digital camera
(Nikon, Yokohama, Japan).
Open software Image J 64, using the MRI Wound
Healing Tool was used to quantify.the damaged area.
Statistical analysis
Three primary cell cultures derived from three different
animals were used. Data represent the mean ± SD (or ±
range of expression for qRT-PCR) of three biological
replicates. Each experiment was repeated two or three
times and the data were analysed by Student’s t-test or
one-way analysis of variance (ANOVA) followed by the
Tukey post hoc comparison Test (see the figure leg-
ends). Differences of at least p < 0.05 were considered
significant. Statistical analysis was carried out by using R
software (http://www.R-project.org) [56].
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